OSTEOTECH, INC (SUBSIDIARY OF MEDTRONIC) GRAFTON DBM; FILLER, BONE VOID, OSTEOINDUCTION (W/O HUMAN GROWTH FACTOR)
|
Back to Search Results |
|
Model Number T43105 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bacterial Infection (1735); Purulent Discharge (1812); Erythema (1840); Headache (1880)
|
Event Date 04/25/2014 |
Event Type
Injury
|
Event Description
|
It was reported that a (b)(6) male patient received allograft bone void filler during a ¿left knee arthroscopy with removal of loose ocd (osteochondritis dissecans) lesion; chondroplasty of the patella and trochlea; open anteromedialization tibial tubercle with distalization 8mm (3 x 4.5 mm low profile cortical screws); bone grafting at tibial tubercle defect site; open excision medial patellar exostosis; open repair patellar sided mpfl (medial patellofemoral ligament) / medial retinaculum." approximately one month later, the patient returned to the er with pus-like drainage from the incision complaining of feeling feverish, erythema and headache.The patient was admitted to the hospital that same day and underwent an open debridement drainage and irrigation.Patient was started on antibiotics.Two days later, the patient was returned to surgery for incision and drainage.Patient was started on additional antibiotics.Another two days later, the patient was again returned to surgery for incision and drainage.The graft remains in the patient.The patient was discharged from the hospital approximately 5 weeks after his readmission.
|
|
Manufacturer Narrative
|
(b)(4).All donor records and manufacturing records relative to the subject graft were reviewed and indicated that the graft was manufactured according to procedure and met all required specifications; all final product sterility and environmental monitoring test results complied.There were no non-conformances associated with the manufacture of the product.The donor records were reviewed by the medical director; the donor was confirmed to have been appropriately screened and tested in accordance with the manufacturer¿s donor suitability criteria, and was deemed eligible for transplantation.All infectious disease tests were non-reactive (compliant).The donor tissue underwent low dose pre-processing irradiation with gamma radiation within the required dosage rate.The tissue recovery organization which provided the donor tissue to the manufacturer was notified of this incident, and they have received no additional reports of infection of any type involving any other tissues procured from this donor.The manufacturer has not received any other reports of infection involving any other grafts manufactured from this lot or from this donor tissue.Based on these findings, the medical director has concluded that there is no medical evidence to indicate that the subject graft caused or contributed to the patient's infection, which occurred one month post-op.No further action is required at this time and this event is considered closed.
|
|
Search Alerts/Recalls
|
|
|